Turmeric as Treatment in Epilepsy
Ključne besede
Povzetek
Datumi
| Nazadnje preverjeno: | 03/31/2018 |
| Prvič predloženo: | 08/14/2017 |
| Predviden vpis oddan: | 08/15/2017 |
| Prvič objavljeno: | 08/17/2017 |
| Zadnja posodobitev oddana: | 04/25/2018 |
| Zadnja posodobitev objavljena: | 04/29/2018 |
| Dejanski datum začetka študija: | 02/28/2018 |
| Predvideni datum primarnega zaključka: | 10/31/2018 |
| Predvideni datum zaključka študije: | 10/31/2018 |
Stanje ali bolezen
Intervencija / zdravljenje
Dietary Supplement: Turmeric Oil
Faza
Skupine rok
| Roka | Intervencija / zdravljenje |
|---|---|
| Experimental: Turmeric Oil stable dose of orally administered turmeric oil | Dietary Supplement: Turmeric Oil Twenty patients will be enrolled and treated with a stable dose of orally administered turmeric oil daily for 3 months. |
Merila upravičenosti
| Starost, primerna za študij | 1 Year Za 1 Year |
| Spol, upravičen do študija | All |
| Sprejema zdrave prostovoljce | Da |
| Merila | Inclusion Criteria: - Patients with greater than greater than six seizures per month diagnosed with Dravet Syndrome, Lennox-Gastaut Syndrome, Tuberous Sclerosis, or focal seizures followed at NYU CEC. Exclusion Criteria: - Patients expected to have changes to any medications or supplements during study period - exposure to any investigational agent in the month prior to study entry - pregnant or breast feeding women, positive pregnancy test - history of non-compliance - known drug or alcohol dependence - known baseline hematologic - liver function - renal function - absorption - absorption |
Izid
Primarni izidni ukrepi
1. Number of epilepsy patients enrolled in study [3 months]
Ukrepi sekundarnega rezultata
1. Number of epilepsy seizures post epilepsy treatment with turmeric [3 months]
